Jan 5, 2016 Cellectar Biosciences Announces Positive Data From Phase 1 Therapeutic Trial of CLR 131 in Multiple Myeloma Learn More
Dec 16, 2015 Cellectar Biosciences and Pierre Fabre Laboratories Announce Oncology Research Collaboration Learn More